How GLP-1 Medications Like Ozempic May Reduce Dementia Risk and Addiction
As the medical community continues to evaluate the expanding therapeutic profile of glucagon-like peptide-1 (GLP-1) receptor agonists, recent clinical investigations have sparked significant interest regarding their potential neurological benefits. Originally developed for the management of type 2 diabetes and, more recently, for chronic weight management, these medications are now the subject of intense scrutiny regarding … Read more